Balchem Corporation Profile Avatar - Palmy Investing

Balchem Corporation

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States an…
Chemicals - Specialty
US, New Hampton [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 50% Balanced
Leverage & Liquidity 17% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 23.37 2.61 2.12
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 29.07 4.68 3.63
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 2.37 33.45 32.68
Cash -6.35 1.87 2.00
Capex 40.30 -0.21 -0.36
Free Cash Flow -52.57 0.82 1.73
Revenue 4.80 7.43 7.09
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 3.72 0.34 0.33
Operating Margin -32.77 0.18 0.26
ROA 11.27 0.02 0.02
ROE 6.27 0.03 0.03
ROIC -31.65 0.02 0.04
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of BCPC is permitted for members.
5 Growth
The "Growth Entry" for the Focus of BCPC is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of BCPC is permitted for members.
End of BCPC's Analysis
CIK: 9326 CUSIP: 057665200 ISIN: US0576652004 LEI: - UEI: -
Secondary Listings
BCPC has no secondary listings inside our databases.